Literature DB >> 20513080

Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35.

Gilbert Cornut1, Simon Gagnon, Catherine Hankins, Deborah Money, Karina Pourreaux, Eduardo L Franco, François Coutlée.   

Abstract

The L1 gene encodes for the major capsid protein of human papillomaviruses (HPV). There is limited information on the polymorphism of L1 for types related to HPV-16. This report explores the polymorphism of L1 in phylogenetically related types 31, 33, and 35 compared to HPV-16. Genital specimens collected from 732 HIV-seropositive and 323 HIV-seronegative women were screened for HPV DNA with consensus L1 PCR. Cervical samples positive for HPV-16 (n = 74), HPV-31 (n = 78), HPV-33 (n = 37), and HPV-35 (n = 58) were further characterized by PCR-sequencing of the complete L1 gene. The number of nucleotide substitutions within L1 ranged from 19 for HPV-33 to 52 for HPV-31. The ratio of the number of variants/number of isolates tested was higher for HPV-31 (56.4%, P = 0.05) and HPV-35 (60.3%, P = 0.04) compared to HPV-16 (40.5%), while this ratio was lower for HPV-33 (24.3%), although not significantly (P = 0.14). The maximal distance between HPV variants was greater in the five putative surface-exposed loops of L1 than in sequences outside the loops (P < 0.01). Synonymous variations were encountered in 1.7% (95% CI 1.1-2.3) of nucleotides inside the L1 loops and 2.4% (95% CI1.2-3.7) of nucleotides outside the L1 loops. Non-synonymous variations were encountered in 1.8% (95% CI 1.1-2.5) of nucleotides within the L1 loops and 0.2% (95% CI 0-0.4) of nucleotides outside the loops. dN/dS ratios were below 1.0 in extra-loop and intra-loop regions, but they were lower in extra-loop regions. These results suggest that sequences within and outside the hypervariable loops of L1 were under selective constraint. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513080     DOI: 10.1002/jmv.21777

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; Zhonghu He; Rachel L Winer; Ayaka Hulbert; Shu-Kuang Lee; Yang Ke; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2012-07-11       Impact factor: 7.396

2.  Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.

Authors:  Sara L Bissett; Anna Godi; Maxime J J Fleury; Antoine Touze; Clementina Cocuzza; Simon Beddows
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

3.  Whole-Genome Sequencing and Variant Analysis of Human Papillomavirus 16 Infections.

Authors:  Pascal van der Weele; Chris J L M Meijer; Audrey J King
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

4.  Prevalence and genetic variability in capsid L1 gene of rare human papillomaviruses (HPV) found in cervical lesions of women from North-East Brazil.

Authors:  Ana Pavla Almeida Diniz Gurgel; Bárbara Simas Chagas; Carolina Maria Medeiros do Amaral; Eugênia Maria Bezerra Albuquerque; Ivi Gonçalves Soares Santos Serra; Jacinto da Costa Silva Neto; Maria Tereza Cartaxo Muniz; Antonio Carlos de Freitas
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

5.  Oncogenic processes.

Authors:  Rita de Cassia Stocco; Franco Peppino Roperto; Lubna Nasir; Marcelo Palma Sircili
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

6.  Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.

Authors:  Audrey J King; Jan A Sonsma; Henrike J Vriend; Marianne A B van der Sande; Mariet C Feltkamp; Hein J Boot; Marion P G Koopmans
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

7.  L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis.

Authors:  Zuyi Chen; Yaling Jing; Qiang Wen; Xianping Ding; Shun Zhang; Tao Wang; Yiwen Zhang; Jianhui Zhang
Journal:  Virol J       Date:  2016-10-07       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.